STOCK TITAN

SS Innovations (NASDAQ: SSII) features CEO interview with Nasdaq MarketSite

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

SS Innovations International, Inc. disclosed that its Chairman and CEO, Dr. Sudhir Srivastava, took part in an interview with Nasdaq’s Live From MarketSite on November 13, 2025, which was published on December 16, 2025. The video can be viewed on Nasdaq’s Live From MarketSite website and via the company’s investor overview page. The company emphasizes that this interview is being furnished, not filed, under Regulation FD and is not incorporated by reference into other SEC reports, and it includes standard cautionary language about forward-looking statements and related risks.

Positive

  • None.

Negative

  • None.
false 0001676163 0001676163 2025-12-16 2025-12-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): December 16, 2025

 

SS INNOVATIONS INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Florida   001-42615   47-3478854
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

05, 3rd Floor, iLabs Info Technology Centre
Udyog Vihar, Phase III,
Gurugram, Haryana, India 
  122016
Address of Principal Executive Office (Street and Number)   (Zip Code)

 

Registrant’s telephone number, including area code: +91 73375 53469

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
Common Stock   SSII   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

As used in this Current Report on Form 8-K (this “Report”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.

   

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On November 13, 2025, Dr. Sudhir Srivastava our Chairman and Chief Executive Officer, gave an interview (the “Interview”) with Nasdaq’s Live From MarketSite. On December 16, 2025, the Interview was published and may be viewed at the Nasdaq Live From MarketSite website at https://www.nasdaq.com/solutions/listings/live-from-marketsite or on the Company’s website at https://ssinnovations.com/investor-overview/.

 

The information set forth in this Item 7.01 and in the Interview, are deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information set forth in this Item 7.01 and in the video interview, including without limitation, information accessed through the links set forth above, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

 

Forward-Looking Statements

 

This Report may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SSi’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and uncertainties, although not all risks and uncertainties, that could cause the Company’s actual results to differ materially from those presented in its forward-looking statements are set forth in the Company’s Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission, as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to SSi’s operations, results of operations, growth strategy and liquidity.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: December 16, 2025 SS INNOVATIONS INTERNATIONAL, INC.
     
  By: /s/ Sudhir Srivastava
    Sudhir Srivastava, M.D.
    Chairman and Chief Executive Officer

 

 

2

 

 

FAQ

What did SS Innovations (SSII) report in this 8-K?

SS Innovations reported under Regulation FD that its Chairman and CEO, Dr. Sudhir Srivastava, participated in a Nasdaq Live From MarketSite video interview that has now been published online.

When was the SSII CEO interview recorded and published?

The interview with SS Innovations’ CEO was conducted on November 13, 2025 and was published on December 16, 2025.

Where can investors watch the SS Innovations (SSII) Nasdaq MarketSite interview?

The interview can be viewed on the Nasdaq Live From MarketSite website at https://www.nasdaq.com/solutions/listings/live-from-marketsite and on the company’s investor overview page at https://ssinnovations.com/investor-overview/.

How is the SS Innovations interview treated for SEC purposes?

The company states that the information in Item 7.01 and in the interview is furnished, not filed, is not subject to Section 18 of the Exchange Act, and is not incorporated by reference into other SEC filings.

Does the SSII Nasdaq interview include forward-looking statements?

Yes. The company notes that the report may contain forward-looking statements about future events or financial performance, which are subject to risks and uncertainties described in its Form 10-K, Form 10-Q and other SEC filings.

What risks does SS Innovations highlight regarding its forward-looking statements?

SS Innovations explains that its forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results, activity levels or performance to differ materially from what is expressed or implied.
SS Innovations

NASDAQ:SSII

SSII Rankings

SSII Latest News

SSII Latest SEC Filings

SSII Stock Data

1.14B
32.86M
83.05%
0.18%
0.04%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
India
FORT LAUDERDALE